Which statement best describes the relationship between immunosuppressant levels and rejection risk?

Which statement best describes the relationship between immunosuppressant levels and rejection risk?

• A. Immunosuppressant levels should be maintained within a therapeutic range to prevent rejection.
• B. They have no effect on rejection risk.
• C. Higher levels always reduce infection risk.
• D. Lower levels always improve graft function.

Answer: (A)

Maintaining immunosuppressant levels within a therapeutic range is essential because it provides the right balance between preventing rejection and avoiding toxicity. When levels are within this window, there is enough immunosuppression to stop the immune system from attacking the transplanted organ, reducing rejection risk. If levels fall below the therapeutic range, the immune response isn’t adequately suppressed, increasing the chance of acute rejection and graft damage. Conversely, levels that are too high heighten the risk of drug toxicity and infections due to excessive immunosuppression, and they don’t necessarily improve graft function. The statement that higher levels always reduce infection risk or that lower levels always improve graft function is incorrect because infection risk rises with over-immunosuppression, and rejection risk rises with under-immunosuppression.

Maintaining immunosuppressant levels within a therapeutic range is essential because it provides the right balance between preventing rejection and avoiding toxicity. When levels are within this window, there is enough immunosuppression to stop the immune system from attacking the transplanted organ, reducing rejection risk. If levels fall below the therapeutic range, the immune response isn’t adequately suppressed, increasing the chance of acute rejection and graft damage. Conversely, levels that are too high heighten the risk of drug toxicity and infections due to excessive immunosuppression, and they don’t necessarily improve graft function. The statement that higher levels always reduce infection risk or that lower levels always improve graft function is incorrect because infection risk rises with over-immunosuppression, and rejection risk rises with under-immunosuppression.